India is a global hub for generic medicines. Because the country has low-cost manufacturing, WHO-GMP compliant production, large-scale capacity, and exports to over 200 countries, supplying more than 20% of global generic drugs.
India is called the “pharmacy of the world”. The country is known for supplying affordable and high-quality medicines across continents. Today, generic medicines from India form the backbone of global healthcare systems in markets like Africa, Latin America (LATAM), and emerging markets.
Indian Pharmaceutical Industry Overview:
At present, the Indian pharmaceutical industry is valued at approximately $50 billion (2024) and is projected to touch $130 billion by 2030.
Key statistics:
- India contributes 20 to 22% of global generic medicine exports (by volume)
- Supplies genuine medicines to 200+ countries across the world
- Accounts for nearly 60% of global vaccine production
- Hosts 10,500+ pharmaceutical manufacturing facilities
- Over 650 US FDA-approved plants (highest outside the USA)
This makes India a leading pharmaceutical exporter from India to global markets.
Why is India called the Pharmacy of the World?
The phrase “why India is the pharmacy of the world” is backed by strong global dependency on Indian medicines.
- Around 1 in 5 generic medicines consumed globally originates from India
- In the United States, ~40% of generic drugs are supplied by Indian companies
- In Africa, 70–90% of medicines are imported from India (by Indian suppliers)
- India exports more than 80 billion doses of generic medicines annually
India’s ability to supply quality medicines in bulk at affordable prices has made it indispensable to global healthcare.
Strength of India’s Generic Medicine Industry:
The Indian generic medicine industry continues to grow because of strong fundamentals:
1. Cost Efficiency:
Indian generic medicines are typically 30 to 80% more affordable than innovator medicines in developed markets.
2. Manufacturing Scale:
India produces:
- Over 500 different APIs (Active Pharmaceutical Ingredients)
- Large volumes of finished formulations across therapy areas
- Wide therapeutic coverage
3. Regulatory Compliance:
Indian manufacturers meet global standards:
- EU-GMP
- PIC/S
- US FDA
- EMA
- WHO-GMP
- SAHPRA
This helps ensure that generic medicines from India are trusted and genuine worldwide.
India Generic Drug Manufacturers: Global Leaders
India is home to some of the world’s largest generic drug manufacturers. The country is known for supplying generic medicines to both regulated and semi-regulated markets.
Key facts:
- India has the highest number of US FDA-approved plants outside the USA
- Over 2,000 WHO-GMP certified manufacturing facilities
- Leading supplier of antiretrovirals (ARVs)- prescribed in HIV treatment worldwide
Indian pharmaceutical companies are also expanding into:
- Biosimilars
- Complex generics
- Specialty therapies
Global Demand for Generic Medicines from India:
Demand for generic medicines from India is exponentially increasing because of:
- Rising healthcare costs across the world
- Aging populations
- Heavy burden of chronic disorders/diseases
Regional Insights:
Africa:
- Imports 70 to 90% of medicines
- Heavy dependence on Indian generics for affordability
Latin America (LATAM):
- Patients wait 60 to 70 months for drug approvals
- Indian generic medicine supply helps reduce access delays
Middle East & Southeast Asia:
- Increasing dependence on EU-GMP/WHO-GMP certified Indian suppliers
India’s Role in Affordable Healthcare Access:
India plays a big role in making healthcare accessible:
- Supplies over 90% of the global antiretroviral drugs used in low-income countries
- Major supplier of tuberculosis (TB), malaria, and HIV medicines
- Provides cost-effective oncology and rare disease treatments (i.e., Triokris for Wilson’s Disease)
This impact is clearly noticeable in countries where healthcare budgets are not as good as they should be.
Compliance and Quality Standards:
Quality is a key element behind India’s global leadership. The pharmaceutical exports from India follow:
- EU-GMP and WHO-GMP standards
- PIC/S and US FDA regulations
- EMA and SAHPRA guidelines
Additionally, exporters ensure:
- Certificate of Analysis (CoA)
- Certificate of Origin (CoO)
- Free Sale Certificate (FSC)
- Batch traceability
- Invoice
- GDP-compliant logistics
This help ensures safe, compliant, and transparent supply chains.
India’s Growing Role in Generic and Specialty Medicines:
India is not limited to only generics. But the country is expanding into:
- Oncology drugs
- Critical care medicines
- Injectable and biologic products
- Rare disease treatments
These therapies are often high-cost in developed markets, making the Indian supply important for global access.
Challenges in the Indian Pharmaceutical Export Market:
Despite its strengths, the Indian pharmaceutical industry faces challenges:
- Regulatory differences across countries
- Import compliance complexities
- Supply chain disruptions
- Documentation inconsistencies from suppliers
However, these challenges also create opportunities for trusted pharmaceutical export partners from India.
How Ikris Pharma Network Supports Global Medicine Access?
Ikris Health Plus leverages the strength of the Indian pharmaceutical industry to support global buyers.
We help:
- Importers, wholesalers, and distributors
- Hospitals and healthcare providers
- NGOs and government organizations
Our Key Capabilities:
- Sourcing from EU-GMP/WHO-GMP certified Indian manufacturers
- Supply of generic, branded, and specialty medicines
- Access to unregistered medicines (where applicable)
- Complete regulatory documentation support
- End-to-end global logistics and cold-chain management
As a trusted generic medicine supplier in India, we have direct contact with the manufacturers and stockists.
Why Global Buyers Choose Indian Generic Drug Manufacturers?
Importers, wholesalers, and healthcare systems always prefer India because:
- Lower cost without compromising quality
- Strong regulatory compliance
- Reliable manufacturing capacity
- Global acceptance of Indian pharma exports
For buyers, this translates to:
- Better margins
- Faster supply
- Wider product availability
India’s Strategic Role in Global Pharma Supply:
India’s dominance in the global pharmaceutical market is driven by a combination of scale, affordability, compliance, and export capability.
As global demand for cost-effective treatments increases, generic medicines from India will continue to play a key role in:
- healthcare costs reduction
- Increasing access to life-saving therapies
- Supporting healthcare systems in emerging markets
For global buyers, partnering with trusted generic medicine suppliers in India like Ikris Health Plus ensures access to high-quality Indian generics with full regulatory compliance and reliable supply chains.
Looking to Source High-Quality Generic Medicines from India?
Whether you are an importer, distributor, hospital, or healthcare organization, accessing a reliable and compliant pharmaceutical supply is critical.
At Ikris Health Plus, we help you:
- Source from WHO-GMP & globally compliant Indian manufacturers
- Access cost-effective generic and specialty medicines
- Navigate regulatory and documentation requirements seamlessly
- Ensure fast, reliable, and temperature-controlled delivery worldwide
Get a Customized Quote in 24–48 Hours:
Avoid delays, compliance problems, and unreliable suppliers. Speak with our pharma export experts today.
Contact us now to witness reliable sourcing of generic and branded medicines from India.
Frequently Asked Questions (FAQs):
1. Why is India called the pharmacy of the world?
India is called the pharmacy of the world because it supplies over 20% of global generic medicines and exports to over 200 countries. The Indian pharmaceutical industry offers affordable, high-quality drugs compliant with EU-GMP, WHO-GMP, US FDA, PIC/S, and EMA standards, making it a global healthcare backbone.
2. What are generic medicines from India, and why are they affordable?
Generic medicines are equivalent versions of branded drugs that provide the same quality, safety, and efficacy. They are more affordable because of lower manufacturing costs, large-scale production, and strong competition among Indian generic drug manufacturers.
3. Who are the leading generic drug manufacturers?
India has over 3,000 pharmaceutical companies and more than 10,500 manufacturing facilities, including many US FDA-approved plants. These Indian generic drug manufacturers supply medicines globally and play a key role in clinical treatments, especially in emerging markets.
4. How does the Indian pharmaceutical industry support global healthcare?
The Indian pharmaceutical industry supports global healthcare by exporting 80+ billion doses of medicines annually, including vaccines, oncology drugs, and treatments for chronic diseases. It plays a major role in improving access in Africa, LATAM, and developing regions.
5. How can importers source generic medicines from India safely?
Importers can source generic medicines from India by working with a trusted bulk drug exporter in India like Ikris Health Plus, who provide WHO-GMP certified sourcing, regulatory documentation, batch traceability, and end-to-end logistics support to ensure compliant and reliable supply.
References:
- Indian Pharmaceutical Industry Overview (IBEF):
- World Health Organization (WHO) – Access to medicines:
- Central Drugs Standard Control Organization (CDSCO) – India regulator:
- US FDA – Drug approvals & manufacturing facilities:
- Pharmexcil (Pharmaceutical Export Promotion Council of India):
- WHO – Good Manufacturing Practices (GMP):
- World Bank – Global healthcare access data:
- UN Comtrade – Global pharmaceutical trade data:
